{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:26:04Z","timestamp":1743899164932,"version":"3.37.3"},"reference-count":10,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1002\/jcph.967","type":"journal-article","created":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T13:32:53Z","timestamp":1502976773000},"page":"1107-1125","source":"Crossref","is-referenced-by-count":4,"title":["Exposure-Response Modeling and Power Analysis of Components of ACR Response Criteria in Rheumatoid Arthritis (Part 2: Continuous Model)"],"prefix":"10.1002","volume":"57","author":[{"given":"Liang","family":"Li","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacology II; Office of Clinical Pharmacology; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology II; Office of Clinical Pharmacology; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"},{"name":"Division of Bioequivalence III; Office of Generic Drugs; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Pharmacometrics; Office of Clinical Pharmacology; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Ji","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology II; Office of Clinical Pharmacology; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Yim","sequence":"additional","affiliation":[{"name":"Division of Pulmonary; Allergy; and Rheumatology Products; Office of New Drugs; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badrul A.","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Division of Pulmonary; Allergy; and Rheumatology Products; Office of New Drugs; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Doddapaneni","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology II; Office of Clinical Pharmacology; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Pharmacometrics; Office of Clinical Pharmacology; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaning","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pharmacometrics; Office of Clinical Pharmacology; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrahas","family":"Sahajwalla","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology II; Office of Clinical Pharmacology; Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"issue":"3","key":"10.1002\/jcph.967-BIB0001|jcph967-cit-0001","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0895-4356(91)90035-8","article-title":"Binary methods for continuous outcomes: a parametric alternative","volume":"44","author":"Suissa","year":"1991","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1002\/jcph.967-BIB0002|jcph967-cit-0002","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/art.21243","article-title":"Use of the American College of Rheumatology N (ACR-N) index of improvement in rheumatoid arthritis: argument in favor","volume":"52","author":"Siegel","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1002\/jcph.967-BIB0003|jcph967-cit-0003","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/art.30402","article-title":"American College of Rheumatology Clinical Trial Priorities and Design Conference, July 22-23, 2010","volume":"63","author":"Force ACoRRACTIAHT","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1002\/jcph.967-BIB0004|jcph967-cit-0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.22552","article-title":"A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response","volume":"57","author":"American College of Rheumatology Committee to Reevaluate Improvement C","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1002\/jcph.967-BIB0005|jcph967-cit-0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10928-014-9385-x","article-title":"Clinical endpoint sensitivity in rheumatoid arthritis: modeling and simulation","volume":"41","author":"Ma","year":"2014","journal-title":"J Pharmacokinet Pharmacodyn"},{"journal-title":"J Clin Pharmacol","article-title":"Exposure-response modeling and power analysis of components of ACR response criteria in rheumatoid arthritis (part 1: binary model) [published online ahead of print 2017]","author":"Li","key":"10.1002\/jcph.967-BIB0006|jcph967-cit-0006"},{"issue":"5 suppl 39","key":"10.1002\/jcph.967-BIB0007|jcph967-cit-0007","first-page":"S109","article-title":"The American College of Rheumatology (ACR) Core Data Set and derivative \u201cpatient only\u201d indices to assess rheumatoid arthritis","volume":"23","author":"Pincus","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1002\/jcph.967-BIB0008|jcph967-cit-0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10928-007-9080-2","article-title":"Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients","volume":"35","author":"Hutmacher","year":"2008","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"2","key":"10.1002\/jcph.967-BIB0009|jcph967-cit-0009","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/0091270012437585","article-title":"Exposure-response relationship of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in a large population of patients with rheumatoid arthritis","volume":"53","author":"Levi","year":"2013","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1002\/jcph.967-BIB0010|jcph967-cit-0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10928-015-9453-x","article-title":"Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritis","volume":"43","author":"Hu","year":"2016","journal-title":"J Pharmacokinet Pharmacodyn"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.967","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.967\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T13:01:39Z","timestamp":1657803699000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.967","archive":["Portico"],"relation":{},"ISSN":["0091-2700"],"issn-type":[{"type":"print","value":"0091-2700"}],"subject":[],"published":{"date-parts":[[2017,8,17]]}}}